Ignite Creation Date:
2024-05-06 @ 12:48 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01662609
Status:
COMPLETED
Last Update Posted:
2022-10-07
First Post:
2012-08-08
Brief Title:
Protocol for High-Risk Assessment Screening and Early Detection of Pancreatic Cancer
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
Protocol for High-Risk Assessment Screening and Early Detection of Pancreatic Cancer at Moffitt Cancer Center and Lehigh Valley Hospital
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out whether Endoscopic Ultrasound EUS can detect early stage pre-cancerous or cancerous changes in the pancreas in patients at high-risk for the development of pancreatic cancer Endoscopic refers to the use of an instrument called an endoscope - a thin flexible tube with a tiny video camera and light on the end Ultrasound refers to an imaging technique that uses sound waves to produce pictures EUS in this research study is a method of combining endoscopy and ultrasound imaging to obtain high quality images of the pancreas
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None